image
Healthcare - Biotechnology - NASDAQ - US
$ 0.3887
-8.77 %
$ 88.7 M
Market Cap
-1.15
P/E
INCOME STATEMENT
28.7 M REVENUE
288.94%
-66.3 M OPERATING INCOME
20.46%
-66.9 M NET INCOME
18.82%
EFFICIENCY
Earnings Waterfall Vaxart, Inc.
image
Revenue 28.7 M
Cost Of Revenue 4.4 M
Gross Profit 24.3 M
Operating Expenses 95 M
Operating Income -66.3 M
Other Expenses 655 K
Net Income -66.9 M
30m30m20m20m10m10m00(10m)(10m)(20m)(20m)(30m)(30m)(40m)(40m)(50m)(50m)(60m)(60m)(70m)(70m)(80m)(80m)29m(4m)24m(95m)(66m)(655k)(67m)RevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income

Income Statement

Millions
Dec-2024 Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Jun-2017 Jun-2016 Jun-2015 Jun-2014 Jun-2013 Dec-2011 Dec-2010 Dec-2009 Dec-2008 Dec-2007 Dec-2006 Dec-2005 Dec-2004 Dec-2003 Dec-2002 Dec-2001 Dec-2000 Dec-1999 Dec-1998 Dec-1997 Dec-1996 Dec-1995 Dec-1994 Dec-1993 Dec-1992 Dec-1991 Dec-1990 Dec-1989 Dec-1988 Dec-1987 Dec-1986 Dec-1985
REVENUE
Revenue 28.7 7.4 0.1 0.9 4.0 9.9 4.2 5.8 8.9 9.3 24.6 68.7 33.6 14.8 35.0 10.5 0 0 89.9 108.1 142.2 176.6 196.0 234.8 228.8 233.6 243.1 228.7 239.9 202.0 164.7 101.6 82.4 68.2 72.8 59.2 47.3 43.1 43.7 34.2
GROSS PROFIT
Cost Of Revenue 4.4 68.1 3.3 48.7 19.9 14.5 17.3 12.4 17.6 100 K 3.6 51.1 19.7 1.5 4.0 2.0 0 0 62.7 67.2 88.1 81.4 119.9 152.6 152.8 155.2 166.9 173.8 174.0 148.1 130.7 78.8 68.4 57.9 61.6 50.8 41.6 38.0 37.4 29.3
Gross Profit 24.3 (60.8) (3.2) (47.9) (15.8) (4.7) (13.1) (6.5) (8.7) 9.2 21.0 17.6 13.9 13.4 31.1 8.5 0 0 27.2 40.8 54.1 95.2 76.0 82.2 76.0 78.4 76.2 54.9 65.9 53.9 34.0 22.8 14.0 10.3 11.2 8.4 5.7 5.1 6.3 4.9
OPERATING INCOME
Operating Expenses 95.0 90.7 110.4 70.6 35.1 20.7 24.0 83 K 36.3 34.3 29.2 27.7 33.5 23.1 32.3 26.5 25.0 44.9 61.3 122.6 106.2 89.7 60.2 (34.8) 72.4 72.6 77.6 60.6 54.7 63.5 16.6 14.3 12.1 7.0 7.9 6.7 4.3 3.8 4.4 3.3
Selling, General and Administrative Expenses 20.8 22.6 29.4 21.9 15.2 6.2 6.7 2.6 5.7 5.6 6.6 6.9 13.6 5.4 6.2 10.0 12.4 26.1 32.6 37.0 46.2 62.3 38.4 52.6 48.3 47.0 44.3 31.6 30.1 56.5 12.2 11.3 9.0 5.8 6.6 5.5 3.6 3.2 3.7 2.7
Research and Development Expenses 74.2 68.1 81.1 48.7 19.9 14.5 17.3 12.4 28.3 26.3 19.8 17.5 15.5 17.8 26.1 16.5 12.6 18.8 28.7 57.8 59.6 29.0 21.1 15.3 14.3 15.5 21.8 19.1 16.7 0 0 0 0 0 0 0 0 0 0 0
Operating Income (66.3) (83.3) (114.6) (72.8) (30.2) (15.8) (21.8) (9.1) (27.5) (25.2) (19.5) (11.5) (22.1) (9.8) (1.2) (18.0) (25.0) (44.9) (61.3) (122.6) (52.0) (12.9) 3.7 117.0 3.6 5.8 (1.4) (5.7) 11.2 (9.6) 17.4 8.5 1.9 3.3 3.3 1.7 1.4 1.3 1.9 1.6
PRE-TAX INCOME
Interest Income Expense 3.0 1.4 1.3 1.5 1.9 2.4 2.7 0 1.8 0.3 0 0 0 0 0.2 1.1 3.9 3.5 3.7 3.1 2.2 1.4 2.1 2.1 3.6 0 5.7 0 4.0 1.9 3.0 3.1 2.5 0.6 0.9 1.1 0.5 0 0.5 0.7
Total Other Income (0.4) 1.1 6.9 2.4 (1.8) (2.4) 3.9 (0.5) (1.7) (0.2) 0.3 0.2 13.3 (2.0) 0.3 (0.8) (0.8) 6.1 7.4 (31.3) 0.9 (0.5) (1.0) (1.0) 0.5 1.8 (14.7) (10.2) (3.2) (1.3) (3.0) (3.1) (1.9) (0.3) (0.3) (0.3) (1.0) (0.3) (0.2) (0.5)
Pre-Tax Income (66.7) (82.2) (107.7) (70.4) (32.0) (18.2) (17.9) (9.6) (29.1) (25.4) (19.2) (11.3) (8.8) (9.5) (0.9) (18.7) (25.7) (38.8) (60.7) (121.5) (51.2) (13.4) 2.7 116.1 4.1 7.6 (16.1) (15.9) 8.0 (10.9) 14.4 5.4 0 3.0 3.0 1.4 0.4 1.0 1.7 1.1
NET INCOME
Tax Provision 0.3 0.3 67 K 0.1 0.2 0.5 0.1 2.9 0.3 0.4 100 K (0.3) 100 K (2.0) (1.8) 1.1 (2.8) (14.3) (0.8) (2.9) 4.7 (6.6) 0.6 11.4 87 K 2.5 20.4 (4.7) (6.2) 6.7 5.8 2.0 2.5 0.8 0.8 0.6 0.2 0.5 0.9 100 K
Net Income (66.9) (82.5) (107.8) (70.5) (32.2) (18.6) (18.0) (12.5) (29.4) (25.4) (19.1) (11.0) (8.9) (4.5) 0.9 (18.7) (18.7) 47.1 (58.7) (128.4) (50.4) (6.8) 2.1 104.7 4.4 3.3 (21.8) (11.2) 13.3 (17.6) 7.9 3.5 (0.6) 2.2 2.2 0.8 0.2 0.5 0.8 1.0
EPS 0.0331 0.057 0.084 0.058 0.036 0.086 0.285 0.329 0.837 0.723 0.594 0.386 0.347 0.706 0.132 2.44 2.38 5.15 6.36 14.2 5.68 0.924 0.264 18.2 0.792 0.66 4.12 2.11 2.51 3.46 3.04 1.68 0.264 0.924 0.924 0.396 0.132 0.198 0.396 0.726